58 /100
HIGH RISK
Score updated Jul 13, 2026

CASI — CASI Pharmaceuticals, Inc. Dilution Risk Tracker

Track CASI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CASI — Get alerts when the score changes →

As of July 13, 2026, CASI Pharmaceuticals, Inc. (CASI) has a DilutionWatch DilutionScore of 58/100, rated HIGH dilution risk. CASI Pharmaceuticals, Inc. has a market capitalization of $3.21M, 20.56M shares outstanding, 2 institutional holders tracked. Key dilution vectors include approximately 10 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
65
📊 Float Risk
57
⚠️ Warrant Exposure
40
🔄Convertible Debt—

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
53%
🔄 Reverse Split 65%
• 50-day avg $0.88 below $1 exchange minimum
• 10 months cash with weak price
🔁 Convertible Conversion 60%
• Major convertible overhang: 156% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise 15%
• Under 12 months cash (10mo)
🔔 Track CASI — Get forecast alerts →

💹 Market Data

Market Cap$3.21M
Shares Outstanding20.56M
Float9.31M
Cash$17.64M
Debt$38.09M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 99.9% shares (2026Q1 vs prior)
2 institutional holders · 960 shares
#1 MORGAN STANLEY 732 shares
#2 SIMPLEX TRADING, LLC 228 shares

📉 Short Interest

Short Interest60.8K
Days to Cover1.0
% of Float0.7%
FINRA data as of Jan 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for CASI Shareholders

CASI Pharmaceuticals, Inc. (CASI) has a DilutionScore of 58/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 13, 2026, updated from SEC EDGAR data.

Cash runway is a key watch item: CASI has approximately 10 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for CASI in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for CASI alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track CASI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CASI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

AGMH ALLR AMSS APC APRE

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for CASI
📊 CASI FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CASI Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.